Is Tarsus Pharmaceuticals Inc (TARS) Stock at the Top of the Biotechnology Industry?

Tarsus Pharmaceuticals Inc (TARS) is near the top in its industry group according to InvestorsObserver. TARS gets an overall rating of 67. That means it scores higher than 67 percent of stocks. Tarsus Pharmaceuticals Inc gets a 85 rank in the Biotechnology industry. Biotechnology is number 53 out of 148 industries.

TARS has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on TARS!

See Full TARS Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Tarsus Pharmaceuticals Inc Stock Today?

Tarsus Pharmaceuticals Inc (TARS) stock is flat -0.03% while the S&P 500 has fallen -0.18% as of 11:10 AM on Monday, Nov 27. TARS is unmoved $0.00 from the previous closing price of $17.32 on volume of 69,248 shares. Over the past year the S&P 500 has risen 14.81% while TARS has gained 3.77%. TARS lost -$3.84 per share the over the last 12 months. Click Here to get the full Stock Report for Tarsus Pharmaceuticals Inc stock.